U.S. Markets open in 3 hrs 48 mins

iRobot Corporation (IRBT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
94.7700+0.42 (+0.45%)
At close: 4:00PM EDT
People also watch
AVAVISRGIPGPSSYSDDD
  • What happened after hours?
  • BOOM...New high. IRBT is now one of the anointed tech stocks and money will pour into it for years. Stock will hit new highs year after year no matter what. $500 in 5 years.
  • In this market, $200 within 18 months...easily.
  • This is a bubble waiting to burst. Don't invest anymore money. No way is a two billion dollar company with a niche market worth 80-90 dollars a share. Expect a decline by next week.
  • What does share price have anything to do with the value of the company? Apple was a 2 billion dollar company at some time. This is a double or triple EASY. Read what the CEO said about the exponential growth happening with robot sales this year. Then think about the other robots waiting in the wings, ready to make our lives easier. No brainer.
  • Market still hasn't caught up here. $150 within 6 months.
  • Why is a 2 billion dollar company worth 80 dollars a share just because of a good quarter? Damn, the market is stupid.
  • IRBT is starting to trade like another anointed stock that money will pile into no matter what for many years to come. Looking for a double from here and a $5+ billion mkt. cap within 12 months. 10 years from now IRBT could be a $50+ billion mkt. cap. company. Buy all you can right now.
  • AXSM (MC $85 M)(Cash $60 M) 5x BIG Phase 3 in various indications targeting large Markets with first interim results in Q3 2017 = 2000% POTENTIAL..UNKNOWN low float Stock !!! A BIG LIFETIME OPPORTUNITY GUYS ! GLTA

    Undiscovered and massive undervalued Biotech Stock with lots of Big News on the way.This Stock is brutally undervalued with a Market cap of just $85 million and $60 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) more than 50% of O/S is owned by Insider and Institutions which is a great sign .

    This undiscovered stock could be the next 10 bagger gem if just one of their 5 ongoing Phase 3 programs is successful .GL

    Axsome (AXSM)

    Market-Cap: $85 Million
    Cash: $60.6 Million(cash runway into the first quarter of 2019.)
    Price:$3.70

    Shares Out: 23 Million

    Anticipated Near-Term Clinical Milestones

    Clinical Trial Initiations: -- Phase 2/3 clinical trial of AXS-05 in AD agitation (2Q 2017)

    Clinical Trial Readouts:

    -- Phase 3 COAST-1 trial of AXS-02 in knee OA associated with BMLs, interim analysis (3Q 2017)

    -- Phase 3 CREATE-1 trial of AXS-02 in CRPS, interim efficacy analysis (4Q 2017)

    -- Phase 3 STRIDE-1 trial of AXS-05 in TRD, top-line data (1Q 2018)

    New Presentation April
    http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY0Mzk1fENoaWxkSUQ9MzcyMTk4fFR5cGU9MQ==&t=1

    HUGE Pipeline targeting Billion Dollar Markets:
    http://axsome.com/wp-content/uploads/2016/11/Axsome_Dec2016_Pipeline.png

    AXS-05 Treatment Resistant Depression in Phase 3 -(Only 1 approved drug for TRD = unmet medical need. 3M patients in the U.S.)

    AXS-05 Agitation in Alzheimer’s Disease in Phase 2/3 -(No approved medication = unmet medical need. 2M patients in the U.S.)

    AXS-02 Complex Regional Pain Syndrome (CRPS) in Phase 3 (Orphan+Fast Track Status) -(No approved drug = high unmet need. 80,000 new cases per year in the U.S.)

    AXS-02 Knee Osteoarthritis (OA) with Bone Marrow Lesions (BMLs) in Phase 3 (SPA & Fast Track) -(7M patients in the U.S.)

    AXS-02 Chronic Low Back Pain(CLBP) with Modic Changes (MCs) in Phase 3 -(1.6M patients in the U.S.)

    Major Shareholders

    Herriott Tabuteau, MD 7 351 729 38,4%
    Fidelity Management & Research Co. 2 361 625 12,3%
    JPMorgan Asset Management (UK) Ltd. 1 432 456 7,48%
    Mark Coleman, MD 647 998 3,38%
    BlackRock Fund Advisors 426 837 2,23%
    Stifel Trust Co., NA 415 279 2,17%
    The Vanguard Group, Inc. 272 189 1,42%
    Lombard Odier Asset Management (USA) Corp. 250 000 1,31%
    JPMorgan Investment Management, Inc. 156 625 0,82%
    SSgA Funds Management, Inc. 134 688 0,70%

  • That was a nice quarter.
  • Hi from Germany- i dont sell until it comes too 500 $ - take a look at the free float, only 20,35%, Inst. Owners hold 79,65% shares
  • I hate to sell this stock but when zack says to buy my move is one week later sell it's been working for me for years
    I got in at 29 goodbye Irobot and thank you
  • Don't let your dog take a dump before this thing starts working.....big mess. Let your dog take a dump at $SBUX, they will serve it for breakfast 😱
  • woo hoo $$$ go roomba $$$
  • Love people. Use things. Not vice-versa. http://dataunion.tistory.com/2299

    [2016-MAY] iRobot Corporation NASDAQ : IRBT Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.5 In other words, the correlation coefficient of the other stock
    dataunion.tistory.com
  • Zacks said to sale when it was 29 a lot of head winds, so that means wait till it hits 100
  • Found a great no fee daytrading newsletter, vist www.PennySt0ckl0l.org and sign up...so glad I did

  • If we are to go off the RSI then you could argue that a pull back next day or so could occur on IRBT before rallying up. google awesome-STOCKS - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
  • IRBT starting to trade like another anointed stock as it continues to hit new highs no matter what the news. This thing could easily hit $100 as the street just pushed it higher and higher with no regard for fundamentals.
  • Current market cap is 1.77B and soon to be a 2 Billion dollar company once the stock hits $74 per share. Moving up into a mid-cap stock has it's benefits as mid-cap stocks have proven themselves as once a "small" player to be thriving with further growth opportunities with less risk. Robotic vacuum cleaners are still somewhat niche but is gaining traction and wider adoption as prices continue to come down while the performance continues to improve.